Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Multiple myeloma is a clonal plasma cell malignancy.
• DNA damage and chromosomal instability are observed in cancer cells.
• A subset of multiple myeloma exhibits poor prognosis, characterized by replicative stress.

Purpose of the Study:

• To investigate the role of ATR in multiple myeloma.
• To explore the impact of oncogenes like MYC on DNA damage.
• To identify novel therapeutic strategies for a poor-prognosis multiple myeloma subset.

Main Methods:

• Analysis of multiple myeloma cell lines and patient samples.
• Assessment of DNA damage, replicative stress, and oxidative stress.
• Inhibition of ATR and evaluation of cell apoptosis and cytotoxicity.

Main Results:

• Multiple myeloma cells exhibit DNA-replicative stress and DNA damage.
• A poor-prognosis subset relies on ATR for survival.
• ATR inhibition or silencing induces apoptosis in these cells.
• Oncogenes induce both replicative and oxidative stress.
• Piperlongumine enhances DNA damage and apoptosis.
• Combined ATR inhibition and piperlongumine show synergistic cytotoxicity.

Conclusions:

• A poor-prognosis multiple myeloma subset has chromosomal instability and stress.
• A synthetic lethal approach combining oxidative stress enhancement and replicative stress targeting induces apoptosis.
• This strategy offers a novel targeted therapy for this patient subset.